3rd Quarter - Report

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$2,600,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"

LobbyistCovered position, as disclosed
KEN W COLE —
ANGELA WALKER RIEMER —
CAROLINE MOODY SCHELLHAS —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); State, Dept of (DOS)

Bills named: H.R. 2495 (112th), H.R. 2735 (112th), H.R. 4348 (112th), S. 1813 (112th)

Health Issues HCR

Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 452 (112th), H.R. 2182 (112th), S. 3817 (112th), S. 1734 (112th)

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC)

Consumer Issues/Safety/Products CSP

Importation Certified Importer Program Dextromethorphan Distribution Dextromethorphan Abuse Reduction PSE Issues Supply Chain Issues Counterfeits

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Animals ANI

E. coli Vaccine for Animals ELDU Ban on Cephalosporin H.R. 1406, Fairness to Pet Owners Act 2011

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
MARY BRIDGET WALSH —

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); State, Dept of (DOS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1406 (112th)

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Executive Office of the President (EOP); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC)

Copyright/Patent/Trademark CPT

Counterfeit Pharmaceuticals Patent Settlements

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE; Commerce, Dept of (DOC); Food & Drug Administration (FDA)

Alcohol and Drug Abuse ALC

Opioid Abuse Prescription Drug Abuse

LobbyistCovered position, as disclosed
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); State, Dept of (DOS); SENATE

Defense DEF

Homeland Security and Defense Issues Surrounding Readiness for a Chemical Nerve Agent Attack or Industrial Accident.

LobbyistCovered position, as disclosed
KEN W COLE —
JOHN PAUL HALLIWELL —
JENNIFER SWENSON WALTON —

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.